Lipoprotein(a): A Genetically Determined, Causal, and Prevalent

Frontiers Causal effects of genetically predicted type 2 diabetes mellitus on blood lipid profiles and concentration of particle-size-determined lipoprotein subclasses: A two-sample Mendelian randomization study

Apolipoprotein(a) isoform size, lipoprotein(a) concentration, and coronary artery disease: a mendelian randomisation analysis - The Lancet Diabetes & Endocrinology

Lipoprotein(a) and Cardiovascular Disease

Non-genetic influences on lipoprotein(a) concentrations - ScienceDirect

Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study - The Lancet Diabetes & Endocrinology

Is Lipoprotein(a) Clinically Actionable with Today's Evidence? The Answer is Yes

Lipoprotein(a) Testing Trends in a Large Academic Health System in the United States

Lipoprotein(a) and Cardiovascular Diseases

Lipoprotein(a) and Cardiovascular Risk

Lipoprotein(a) Concentration and Risks of Cardiovascular Disease and Diabetes - ScienceDirect

Repeat Measures of Lipoprotein(a) Molar Concentration and Cardiovascular Risk

Lipoprotein(a) in patients with breast cancer after chemotherapy: exploring potential strategies for cardioprotection, Lipids in Health and Disease

Frequent LPA KIV-2 Variants Lower Lipoprotein(a) Concentrations and Protect Against Coronary Artery Disease

Lipoprotein (a) CME Continuing Medical Education